Stephan Toutain - 12 Jun 2025 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role: Chief Operations Officer
Signature: /s/ Spencer Brown, Attorney-in-Fact
Issuer symbol: PDSB
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 25 Jul 2025, 18:12:47 UTC
Previous filing: 02 May 2024
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Toutain Stephan	Chief Operations Officer	C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON	/s/ Spencer Brown, Attorney-in-Fact	25 Jul 2025	0001681658

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PDSB	Employee Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	12 Jun 2025	Common Stock	150,000	$1.79	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.